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ABSTRACT
Background: Postoperative pain control after laparo-
scopic ventral hernia repairs remains a significant clinical
problem. We sought to determine the pain-sparing effi-
cacy of local anesthetic infiltrated into the abdominal wall
wounds created by the placement of transabdominal su-
tures used to ensure adequate fixation of the mesh during
laparoscopic ventral hernia repair.
Methods: Patients undergoing laparoscopic ventral/inci-
sional hernia repair were randomized to receive local
anesthesia (0.25% bupivacaine with epinephrine) into all
layers of the abdominal wall to the level of the parietal
peritoneum at suture fixation sites immediately before
suture placement (Group I; n9) or no local anesthesia
(Group II, control; n9). The anesthetic technique was
otherwise standard for both groups. Postoperatively, pain
was assessed with a 10-point visual analogue scale (VAS)
at 1, 2, 4, and 24 hours. Analgesic use and hospital stay
were also recorded.
Results: The groups were similar in age, sex, ASA, and
size of hernia defect. The operative times were not statis-
tically different between the 2 groups (Group I, 11812
minutes; Group II, 14421 minutes; P0.05). Group I had
a statistically significant decrease in the pain scores com-
pared with Group II (2.20.8 vs. 6.40.9; P0.05) at 1
hour postoperatively. At 2 and 4 hours, the mean pain
scores were decreased but not statistically different. Sim-
ilarly, the cumulative consumption of pain medication at
1, 2, and 4 hours postoperatively as well as the average
hospital stay (Group I, 2.00.4; Group II, 2.40.4 days)
were lower but not statistically significant in patients in
Group I compared with those in Group II.
Conclusion: This small, randomized study demonstrates
that infiltration of suture fixation sites is effective in reduc-
ing early postoperative pain but not analgesic consump-
tion following laparoscopic incisional and ventral hernia
repairs. A larger study is required to investigate this strat-
egy on later postoperative pain and hospital stay.
Key Words: Local anesthesia, Laparoscopic ventral her-
nia repair.
INTRODUCTION
Ventral hernia repairs are often associated with substantial
postoperative pain, frequently requiring narcotic analge-
sics. Although early postoperative pain is less intense with
laparoscopic techniques compared with that in open re-
pair, early postoperative pain after laparoscopic ventral
hernia repair remains an issue. Early postoperative pain
can decrease early ambulation, delay the return of bowel
function, and be a major problem in the acceptance of
early discharge by patients.1–3 Thus, attenuation of early
postoperative pain remains an important concern for sur-
geons.
Opioids are often used to decrease pain following surgery
but are associated with many unwanted side effects and
may not be completely effective. Local anesthetic may
offer a reasonable alternative to opiate use. Because of its
simplicity, safety, and low cost, intraoperative instillation
of local anesthesia is increasingly being used by many
surgeons in an effort to alleviate the postoperative pain
experienced after laparoscopic procedures.3–6 Despite
widespread use of local anesthesia, there is still little
consensus on when (ie, pre- or postincisional), where (ie,
anatomic tissue space) and after which surgical proce-
dures local anesthesia may provide clinically relevant al-
leviation of postoperative pain. To our knowledge, no
study has investigated the benefit of local anesthetic infil-
tration in reducing the postoperative pain experienced
after laparoscopic ventral hernia repairs. We hypothesize
that part of the pain experienced after this procedure
stems from the trauma caused to the anterior abdominal
wall by the placement of the transabdominal sutures used
to fix the mesh material across the hernia defect. There-
fore, in the present study, we sought to determine the
effect of bupivacaine infiltrated at all transabdominal su-
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SCIENTIFIC PAPERture fixation sites during laparoscopic ventral hernia re-
pair on postoperative pain.
METHODS
Our Institutional Board Review approved the study, and
all patients gave written informed consent. All patients
with an incisional or ventral hernia defect 9c m
2 were
considered for enrollment into this study. Patients with a
history of alcohol or drug abuse, chronic pain, pregnancy,
or intolerance or adverse reaction to bupivacaine were
excluded from the study. Eligible patients were random-
ized using a computer-generated randomization schedule
into one of 2 groups. Group I (treatment) received 0.25%
bupivacaine with epinephrine at all transabdominal suture
fixation sites down to the level of the parietal peritoneum
before suture placement. Group II (no treatment; control)
received no bupivacaine injections.
All patients underwent mechanical bowel preparation
with one gallon of polyethylene glycol one day before
surgery. Patients were instructed preoperatively concern-
ing the use of a 10-point linear visual analog pain scale
(VAS) (0no pain to 10excruciating pain). Patients were
given a second-generation cephalosporin as antimicrobial
prophylaxis before induction of anesthesia and 24 hours
postoperatively. Anesthesia was induced with propofol (2
mg/kg to 3 mg/kg) and fentanyl (1.5 mg/kg). After intu-
bation, anesthesia was maintained with isoflurane (1%),
O2/N (30%/70%). No additional narcotics were given in
the operating room.
One surgeon (C.B.) performed the laparoscopic ventral
hernia repairs. Nasogastric suction and bladder catheter-
ization were used for the duration of the operation. A
12-mm port was placed away from the hernia defect in the
left hypochondrium by using the open technique (Has-
son’s trocar). Pneumoperitoneum was then established by
CO2 insufflation and maintained at intraabdominal pres-
sures of 10mm Hg to 12mm Hg. Four accessory trocars (5
mm) were then inserted under direct vision. Adhesiolysis
and reduction of the hernia sac were performed using
sharp dissection. After complete reduction of the hernia
sac and contents, the hernia defect was measured, and the
mesh was prepared.
Polytetrafluoroethylene (PTFE) mesh (Gore-Tex Du-
alMesh Plus Biomaterial, WL Gore, Flagstaff, AZ) was used
to repair all hernia defects. The mesh was tailored to
overlap the hernia wall defect circumferentially by at least
4 cm. Four nonabsorbable Gore-Tex sutures were placed
in the mesh, and the mesh was introduced through the
12-mm trocar into the abdominal cavity and positioned
intracorporeally. In Group I, the transabdominal suture
fixation sites were injected with local anesthesia. The
injection was performed using a 20-gauge spinal needle
inserted down to the level of the parietal peritoneum. The
peritoneum was infiltrated under direct vision and a peri-
toneal bleb was created at each site of injection. The
needle was then withdrawn while the local anesthesia was
continuously injecting up to the level of the skin. A total of
approximately 10 mL of 0.25% bupivacaine was injected at
each site. The sutures were then pulled through the ab-
dominal wall using a Gore suture passer. In every case,
the transabdominal sutures were placed every 5 cm to 6
cm apart, and helicoidal clips (Protack, 5 mm; Autosuture
USSC) were placed every 2cm circumferentially.
Immediately on arrival to the recovery room, morphine
was given in increments of 1mg every 6 minutes as
needed for analgesia until patients were comfortable. Pain
intensity was scored using the 10-point visual analogue
score (VAS) at 1, 2, 4, and 24 hours postoperatively from
the time of extubation. At 1, 2, 4, and 24 hours after
surgery, the presence of nausea, vomiting, or both, and
cumulative consumption of analgesic were also recorded.
The time to first analgesia use was documented. A re-
search assistant who was blinded to the treatment re-
ceived, carried out all data collection. After the discharge
from the recovery room, all patients were connected to a
patient-controlled analgesia (PCA) device set to deliver 1
mg of morphine every 6 minutes, without basal infusion
for the first 24 hours. Patients were then changed to oral
pain medication as tolerated. After discharge, patients
were scheduled for a 2-week clinic visit at which time
complications were recorded.
Statistical Analyses
Data are reported as the mean  standard error of the
mean. Statistical analysis was performed using a Mann-
Whitney U-test, or unpaired Student t test as appropriate.
Analyses were performed using a statistical package (In-
Stat). P0.05 was considered statistically significant.
RESULTS
Nineteen patients were enrolled in the study. Sixteen were
considered morbidly obese as assessed by body mass
index 30. The body mass index range was 27 to 60, with
a mean of 38.12.2. Age ranged from 32 to 83 years of
age, with a mean of 55.53.9 years. Ventral hernia pre-
sentation was primary in 9 patients (50%) and incisional in
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270 cm
2, with a mean of 94.719.8.
Nine patients were randomized to receive local anesthesia
(0.25% bupivacaine with epinephrine) into all layers of
the anterior abdominal wall to the level of the parietal
peritoneum at suture fixation sites immediately before
transabdominal suture placement (Group I) and 10 to
receive no local anesthesia (Group II, control). One pa-
tient in Group II failed extubation, leaving 9 patients
randomly assigned to each group for analysis. The groups
did not differ in age, body mass index (BMI), ASA status,
or hernia defect size (cm
2) (Table 1). There were 4 fe-
males in Group I and 7 in Group II (Table 1).
A mean of 99.75.1 mL of local anesthetic was used per
patient in Group I, and there were no significant side
effects from the administration of bupivacaine. The mean
duration of surgery, and the number of transabdominal
sutures was found to be comparable between the 2
groups (Table 2). All cases were completed laparoscopi-
cally without any intraoperative complications or need for
conversion to an open operation. Six patients experienced
nausea after the operation (Table 2). Of these, only one
experienced an episode of vomiting. One Group II death
occurred due to pulmonary embolism.
Following our laparoscopic ventral hernia repair, more
patients in the control group (56%) complained of intense
postoperative pain, defined by a VAS 7, during the first
hour than in our treatment group (11%). Moreover, as
shown in Table 3, the mean VAS pain scores at one hour
postoperatively were significantly lower in Group I (treat-
ment) compared with that in Group II (no treatment,
control). These pain scores continued to be lower on
average in Group I at 2 and 4 hours after the operation
compared with those in Group II; however, this difference
was not statistically different (P0.05; Table 3).
Fewer patients in Group I requested narcotics within the
first hour postoperatively (66%) compared with patients in
Group II (100%), and the time to first request for analge-
sics was longer in Group I (Table 2). The cumulative
consumption of parenteral opioids at 1, 2, and 4 hours
postoperatively (Figure 1) was also lower on average in
Group I, although not statistically significant. The mean
Figure 1. Cumulative narcotic use after laparoscopic ventral
hernia repairs in Group I (bupivacaine; closed diamonds) and
Group II (control; open triangles). The cumulative dose is ex-
pressed in milligrams. The difference between the groups at all
time points was not statistically significant (P0.05; n9 in each
group).
Table 1.
Demographic and Clinical Characteristic Data on the 2 Groups
of Patients
Characteristics Group I
N9
Group II
N9
P Value
Age (years) 51.14.3* 59.95.6* 0.23
Sex (M/F) 5/4 2/7
ASA (median) 3
† 2
†
BMI (meanSEM kg/m
2) 413.4* 35.38.1* 0.21
Hernia type
(incisional/ventral)
3/6 6/3
Hernia defect (cm
2) 72.827.9* 116.827.6* 0.28
*MeanSEM.
Table 2.
Operative and Postoperative Details on the 2 Groups
of Patients
Patient Details Group I Group II P Value
Operative Time
(meanSEM min)
11812.2 144.120.9 0.30
Suture fixation sites
(meanSEM)
9.00.7 10.90.9 0.12
N/V (#) 2/0 4/1
Hospital Stay
(meanSEM days)
2.00.4 2.40.4 0.49
Patients not requiring
postoperative analgesia (#)
11
Time delay to first
postoperative analgesia
(meanSEM min)
57.514.1 308.0 0.11
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nificantly different between the 2 groups (24.17.2mg
Group I, vs. 26.39.2mg Group II; P0.05). Despite a
trend towards reduced analgesia requirements in Group I,
the mean hospital stay was not significantly different (Ta-
ble 2).
On 2-week follow-up, seroma formation was found in 2
patients (11%; one in each group), both of which resolved
with conservative management.
DISCUSSION
Pain remains a relevant complaint during the early post-
operative period leading to the increased consumption of
pain medications, delayed bowel function, and extended
hospital stays. In an effort to address these pain-related
complications, a number of clinical studies have been
conducted using local anesthetics infiltrated at various
times and anatomic locations during several types of open
and laparoscopic surgery.3–12 However, reported results
from these studies are inconsistent, ranging from consid-
erable pain reduction to no significant pain reduction.
Furthermore, the clinical benefit of any reduction in post-
operative pain is questionable because only small reduc-
tions in supplemental analgesic use were observed,10–12
and hospital stays were not significantly reduced.6,7 Con-
sequently, the debate continues not only for which surgi-
cal procedures local anesthesia may provide clinically
relevant alleviation of postoperative pain but also when
(ie, timing of infiltration), where (ie, anatomic site), and
how much (ie, dosage) local anesthesia should be used.
Notably, one surgical procedure where the efficacy of
local anesthetics has not been investigated is laparoscopic
ventral herniorrhaphy.
Our clinical observation suggests that patients often have
considerable discomfort after laparoscopic ventral hernia
repair. It has been stated that several mechanisms are
responsible for pain after laparoscopy. One mechanism is
trauma/injury to the abdominal wall. During laparoscopic
incisional hernia repair, mesh is used to guarantee a ten-
sion-free repair of the hernia defect. Unfortunately, injury
to the anterior abdominal wall is created in large part by
the placement of the transabdominal sutures used to en-
sure adequate fixation of this mesh material. This mesh
fixation is critical because it reduces the rate of recurrent
hernia formation.13 We hypothesized that application of
local anesthetics to these suture fixation sites could atten-
uate the associated pain.
Our findings indicate that bupivacaine infiltration into all
layers of the anterior abdominal wall, including the cuta-
neous tissue, muscle and parietal peritoneum, at the su-
ture fixation sites significantly reduces the early postop-
erative pain after laparoscopic ventral hernia repair. A
number of published studies have strongly suggested that
the anatomic application site of the local anesthetic has a
great contribution to its effectiveness in reducing postop-
erative pain. For example, Yndgaard and colleagues14
demonstrated that lidocaine was more effective when
applied subfascially compared with subcutaneously after
inguinal hernia repair.14 Furthermore, other investigators
have demonstrated that infiltration of the parietal perito-
neum after laparoscopic cholecystectomy and appendec-
tomy was more effective in the control of postoperative
pain compared with subcutaneous infiltration only.15,16 It
would not be unreasonable to expect additional pain
relief if the parietal peritoneum is also infiltrated, because
it is richly innervated with somatic nerve fibers.
In our study, the patients may have gained additional
benefits not only from the anatomic location of the ad-
ministered local anesthesia but also from its infiltration
into the tissue before it was damaged by the placement of
the transabdominal sutures. The theory behind preinci-
sional infiltration of local anesthetics is that it blocks the
nociceptive impulses from reaching the central nervous
system and thereby suppresses the increased excitability
of the spinal cord neurons, which are responsible for
intense pain, that are triggered by these afferent impuls-
es.17–19 Although a debatable topic, the administration of
local anesthetics into wounds before the incision has been
demonstrated to significantly reduce postoperative pain in
many kinds of surgery.20–22 Moreover, several investiga-
tors have noted that postoperative pain was better con-
trolled with preincisional than postincisional infiltration of
local anesthesia.23,24 In fact, Lee and colleagues25 demon-
strated lower pain scores and less narcotic requirement
after laparoscopic cholecystectomy when the local anes-
thetic injections were given before the actual skin incision,
trocar placement, or both.25
Table 3.
Visual Analogue Scores (VAS) of Pain Obtained
Postoperatively on the 2 Groups of Patients
VAS
Scores
Group I
(meanSEM)
Group II
(meanSEM)
P
Value
At 1 hr 2.20.8 6.40.9 0.006
At 2 hr 3.10.9 3.91.1 0.66
At 4 hr 1.10.4 2.60.9 0.27
At 24 hr 2.30.8 2.31.0 0.93
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however, its effectiveness in reducing postoperative pain
appears short-lived. From reviewed trials, reported doses,
ranging up to 150mg have been shown to be safe during
laparoscopic procedures,4 but the pain reduction gener-
ally persists for only 1 hour to 8 hours postoperative-
ly.5,6,26,27 In our study, an average dose of 90mg was used,
and none of our patients experienced toxic side effects to
bupivacaine. However, the analgesic effect was brief with
pain scores only significantly reduced in the first hour
after the operation. These data may reflect the pharmaco-
logical properties of bupivacaine which, depending on
the dose and local tissue absorption, have an elimination
half-life of only 1.5 hours to 5.5 hours.28 In theory, a
continuous infusion of bupivacaine may provide longer-
lasting pain reduction. Currently, infusion pumps are
available that can deliver a constant rate of local anesthe-
sia via specialized catheters placed into surgical incisions.
Several recent studies have demonstrated significant pain
reduction (up to 24 hours) after inguinal hernia repair
using a continuous infusion of local anesthesia.29,30 Ac-
cordingly, we attempted to laparoscopically place these
infusion catheters just above the parietal peritoneum after
a laparoscopic ventral hernia repair, but found significant
leakage of the local anesthesia from the catheter site, as
well as, the inability to infuse the local anesthesia, thus we
abandoned this technique.
In our study, reduced pain scores were associated with a
clear trend towards reduced narcotic consumption; how-
ever, this difference in narcotic administration did not
reach statistical significance. These data are consistent with
data from other trials, evaluating the effectiveness of local
anesthesia after laparoscopic cholecystectomy.10–12,31 The re-
sults from our series also did not translate into a significant
reduction in hospital stay. However, it is conceivable that a
larger study on the effects of local anesthesia after ventral
hernia repair could detect significant improvement in nar-
cotic consumption and hospital stay.
CONCLUSION
The current situation in postoperative pain management
after laparoscopic ventral hernia repair indicates room for
improvement. This study suggests that patients experi-
ence a significant amount of subjective acute pain relief
when the transabdominal suture fixation sites are infil-
trated with local anesthesia, before placement, to the level
of the parietal peritoneum during laparoscopic ventral
herniorrhaphy. We believe that this infiltration of local
anesthetic may be a useful adjunct as part of a multimodal
analgesic regimen to further alleviate the postoperative
pain experienced after this procedure. Because bupiva-
caine is inexpensive, easy to use, readily available, and
has limited side effects, this technique can be easily
adopted. Our results while interesting must be interpreted
cautiously within the context of this relatively limited
series of patient. This area needs larger randomized trials
to enable clinicians to establish whether this method has a
role in daily practice.
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